Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14727679 | 0.92 | HTT (0.50) | POLBAPEX1HTTTDP1GPR119 | |
| SCHEMBL14727702 | 0.85 | KMT2A (0.41) | MEN1KMT2ANFKB1NFKB2RELA | |
| SCHEMBL14727703 | 0.85 | GPR119 (0.36) | GPR119TSHRKMT2A | |
| SCHEMBL14727673 | 0.82 | KMT2A (0.44) | POLBAPEX1HTTTDP1TSHR | |
| SCHEMBL14727681 | 0.81 | KMT2A (0.40) | GPR119TSHRMEN1KMT2ALMNA | |
| SCHEMBL14727684 | 0.80 | KMT2A (0.38) | GPR119MEN1KMT2A | |
| SCHEMBL14727696 | 0.79 | GPR119 (0.39) | POLBAPEX1HTTTDP1GPR119 | |
| SCHEMBL16093590 | 0.79 | KMT2A (0.40) | GPR119MEN1KMT2A | |
| SCHEMBL14727675 | 0.78 | KMT2A (0.39) | GPR119TSHRMEN1KMT2A | |
| SCHEMBL14727672 | 0.78 | KMT2A (0.40) | MEN1KMT2ANFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8840807-B2 | Polymerizable compound | JNC CORPORATION (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20130048912-A1 | POLYMERIZABLE COMPOUND | JNC PETROCHEMICAL CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048912-A1 | POLYMERIZABLE COMPOUND | PYM1, ZYX, CPNE4 | POLB 2029/4885APEX1 1228/4885HTT 3868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.